Tony Moses

What’s next for cell-based proteins: Moses joins Refrigerated & Frozen Foods podcast

Sep 9, 2022

With a global population estimated to hit 9.2 billion by 2050, the food industry is challenged to innovate to respond to a growing need for food. Many investors are drawn to cell-based companies, including names like Bill Gates and companies like Tyson and Cargill. Countries around the world are doubling down on research and regulatory framework for this evolving market. The cell-based protein industry is evolving by the minute and CRB’s Tony Moses, Ph.D. joins Refrigerated & Frozen Foods editor-in-chief Kelley Rodriguez to discuss where the cell-based protein currently stands and what’s next on the latest episode of “From the Cold Corner.”

“It’s a really exciting time to be in the food and beverage industry. There have been tremendous amounts of venture capital raised in cell-based protein and that has several positive consequences for the industry. First, there’s new talent entering, very motivated by sustainability, and it’s been inspiring for the rest of the industry. Second, this talent is coming in with a biotech or biopharma background, so we’re seeing new technologies emerge as food technology and equipment intersect with biopharma. Third, new food and beverage hubs are popping up. Traditionally, Chicago and Twin Cities have been a hub. And now, San Francisco and Boston are emerging. There are new conduits to talent and capital within the industry.” - Tony Moses, Ph.D.

Listen to “What’s Next for Cell-Based Proteins” on From the Cold Corner.

Want to learn more about the reward and risk of alternative proteins? Download Horizons: Alternative Proteins.

Follow CRB on LinkedIn